Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovarian disease

Eur J Obstet Gynecol Reprod Biol. 1989 Feb;30(2):151-6. doi: 10.1016/0028-2243(89)90062-2.

Abstract

Several reports have shown elevated circulating beta-endorphin (beta-EP) levels in patients with polycystic ovarian disease (PCOD). However, it is not yet clear whether these high beta-EP levels are linked to the etiopathogenesis of PCOD or are secondary to the obesity. In the present study we measured beta-EP plasma concentrations in 19 PCOD patients, 10 with normal weight (Group A) and 9 with excessive weight (Group B), and in 18 normally ovulating women, 10 with normal weight (Group C) and 9 with excessive weight (Group D). beta-EP values were similar in the two groups of non-obese patients and controls. beta-EP concentrations were also similar in the two groups of obese patients and controls, and they were significantly higher (p less than 0.05) than in non-obese patients. Our data indicate that in PCOD, elevated beta-EP values are related to obesity, suggesting that they are not linked to the pathogenesis of PCOD.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Luteinizing Hormone / blood
  • Obesity / blood*
  • Polycystic Ovary Syndrome / blood*
  • Polycystic Ovary Syndrome / etiology
  • Sex Hormone-Binding Globulin / metabolism
  • beta-Endorphin / blood*

Substances

  • Sex Hormone-Binding Globulin
  • beta-Endorphin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone